Age-related memory decline is associated with vascular and microglial degeneration in aged rats

Behavioural Brain Research

Volumn 235, Issue 2, 2012, Pages 210-217

  Zhang, Rong ^a   Kadar, Tamar ^a,c   Sirimanne, Ernest ^a   MacGibbon, Alastair ^b   Guan, Jian ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b LactoPharm ^*  (New Zealand)

^c ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Glial degeneration; Hippocampus; Memory; Normal aging; Vascular degeneration and VEGF expression

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GROUPS BY AGE; HIPPOCAMPUS; IMMUNOCHEMISTRY; LATENT PERIOD; MALE; MAZE TEST; MEMORY DISORDER; MICROGLIA; NERVE CELL DEGENERATION; NERVE CELL NETWORK; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGE FACTORS; AGING; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, SURFACE; BRAIN; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; LOCOMOTION; MALE; MAZE LEARNING; MEMORY DISORDERS; MICROGLIA; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE TYPE I; RATS; SWIMMING; TYROSINE 3-MONOOXYGENASE; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84865426876     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.08.002     Document Type: Article

References (49)

1. Rosenzweig E.S., Barnes C.A. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Progress in Neurobiology 2003, 69:143-179.
2. Driscoll I., Sutherland R.J. The aging hippocampus: navigating between rat and human experiments. Reviews in the Neurosciences 2005, 16:87-121.
3. Rapp P.R., Deroche P.S., Mao Y., Burwell R.D. Neuron number in the parahippocampal region is preserved in aged rats with spatial learning deficits. Cerebral Cortex 2002, 12:1171-1179.
4. Rapp P.R., Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:9926-9930.
5. Smith T.D., Adams M.M., Gallagher M., Morrison J.H., Rapp P.R. Circuit-specific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. Journal of Neuroscience 2000, 20:6587-6593.
6. Rossi D., Volterra A. Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Research Bulletin 2009, 80:224-232.
7. Pivneva T.A. Microglia in normal condition and pathology. Fiziologicheskii Zhurnal 2008, 54:81-89.
8. Carmignoto G., Gomez-Gonzalo M. The contribution of astrocyte signalling to neurovascular coupling. Brain Research Reviews 2010, 63:138-148.
9. Jakovcevic D., Harder D.R. Role of astrocytes in matching blood flow to neuronal activity. Current Topics in Developmental Biology 2007, 79:75-97.
10. Pati S., Orsi S.A., Moore A.N., Dash P.K. Intra-hippocampal administration of the VEGF receptor blocker PTK787/ZK222584 impairs long-term memory. Brain Research 2009, 1256:85-91.
11. Quaegebeur A., Lange C., Carmeliet P. The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 2011, 71:406-424.
12. Tayebati S.K., Di Tullio M.A., Amenta F. Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. Clinical and Experimental Hypertension 2004, 26:363-373.
13. Tayebati S.K., Lokhandwala M.F., Amenta F. Dopamine and vascular dynamics control: present status and future perspectives. Current Neurovascualar Research 2011, 8:246-257.
14. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. European Heart Journal 2011.
15. Krum J.M., Rosenstein J.M. VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Experimental Neurology 1998, 154:57-65.
16. Breier G. Functions of the VEGF/VEGF receptor system in the vascular system. Seminars in Thrombosis and Hemostasis 2000, 26:553-559.
17. Krum J.M., Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Experimental Neurology 2003, 181:241-257.
18. Hoenig M.R., Bianchi C., Rosenzweig A., Sellke F.W. Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Current Molecular Medicine 2008, 8:754-767.
19. Rosenstein J.M., Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Experimental Neurology 2004, 187:246-253.
20. Jacobson J., Zhang R., Elliffe D., Chen K., Mathai S., McCarthy D., et al. Co-relation of cellular changes and spatial memory during aging in rats. Experimental Gerontology 2008, 43:928-938.
21. Guan J., Zhang R., Dale-Gandar L., Hodgkinson S., Vickers M. NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat. Behavioural Brain Research 2010, 210:7.
22. Guan J., Waldvogel H.J., Faull R.L., Gluckman P.D., Williams C.E. The effects of the N-terminal tripeptide of insulin-like growth factor- 1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience 1999, 89:649-659.
23. Svedin P., Guan J., Mathai S., Zhang R., Wang X., Gustavsson M., et al. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat. Developmental Neuroscience 2007, 29:393-402.
24. Shapira S., Mathai S., Zhang R., Guan J. Delayed peripheral administration of the N-terminal tripeptide of IGF-1 (GPE) reduces brain damage following microsphere induced embolic damage in young adult and aged rats. Neuroscience Letters 2009, 454:53-57.
25. Guan J., Mathai S., Harris A.P., Wen J.Y., Zhang R., Brimble M.A., et al. Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor funcion following hypoxia-ischemia in adult rats. Neuropharmacology 2007, 53:749-762.
26. Zhang R., Ashton J., Horii A., Darlington C.L., Smith P.F. Immunocytochemical stereological analysis of GABA(B) receptor subunit expression in the rat vestibular nucleus following unilateral vestibular deafferentation. Brain Research 2005, 1037:107-113.
27. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Advance in Gerontology 2002, 10:35-39.
28. Backman L., Lindenberger U., Li S.C., Nyberg L. Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues. Neuroscience and Biobehavioral Reviews 2009, 34:670-677.
29. Furmark T. Neurobiological aspects of social anxiety disorder. Israel Journal of Psychiatry and Related Sciences 2009, 46:5-12.
30. Ohlin K.E., Francardo V., Lindgren H.S., Sillivan S.E., O'Sullivan S.S., Luksik A.S., et al. Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain 2011, 134:2339-2357.
31. Threlfell S., Cragg S.J. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Frontiers in Systems Neuroscience 2011, 5:11.
32. Frick K.M., Burlingame L.A., Delaney S.S., Berger-Sweeney J. Sex differences in neurochemical markers that correlate with behavior in aging mice. Neurobiology of Aging 2002, 23:145-158.
33. Hayakawa N., Abe M., Eto R., Kato H., Araki T. Age-related changes of NGF, BDNF, parvalbumin and neuronal nitric oxide synthase immunoreactivity in the mouse hippocampal CA1 sector. Metabolic Brain Disease 2008, 23:199-211.
34. Streit W.J., Miller K.R., Lopes K.O., Njie E., Sparks D.L., Conde J.R., et al. Microglial degeneration in the aging brain-bad news for neurons?. Frontiers in Bioscience 2008, 13:3423-3438.
35. Lopes K.O., Sparks D.L., Streit W.J., Conde J.R. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 2008, 56:1048-1060.
36. Aliev G., Li Y., Palacios H.H., Obrenovich M.E. Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2011, 6:222-241.
37. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S., et al. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Research. Molecular Brain Research 1998, 59:119-134.
38. Cao Y., Gunn A.J., Bennet L., Wu D., George S., Gluckman P.D., et al. Insulin-like Growth Factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep. Journal of Cerebral Blood Flow and Metabolism 2003, 23:739-747.
39. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiology of Aging 1993, 14:421-429.
40. Berciano M.T., Andres M.A., Calle E., Lafarga M. Age-induced hypertrophy of astrocytes in rat supraoptic nucleus: a cytological, morphometric, and immunocytochemical study. Anatomical Record 1995, 243:129-144.
41. Amenta F., Bronzetti E., Sabbatini M., Vega J.A. Astrocyte changes in aging cerebral cortex and hippocampus: a quantitative immunohistochemical study. Microscopy Research and Technique 1998, 43:29-33.
42. Riekse R.G., Leverenz J.B., McCormick W., Bowen J.D., Teri L., Nochlin D., et al. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study. Journal of the American Geriatrics Society 2004, 52:1442-1448.
43. de la Torre J.C. Alzheimer's disease: how does it start?. Journal of Alzheimer's Disease 2002, 4:497-512.
44. Henry-Feugeas M.C., Onen F., Claeys E.S. Classifying late-onset dementia with MRI: is arteriosclerotic brain degeneration the most common cause of Alzheimer's syndrome?. Clinical Interventions in Aging 2008, 3:187-199.
45. Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor. FEBS Journal 2009, 276:4636-4643.
46. Hayakawa N., Kato H., Araki T. Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector. Mechanisms of Ageing and Development 2007, 128:311-316.
47. Hattiangady B., Shetty A.K. Aging does not alter the number or phenotype of putative stem/progenitor cells in the neurogenic region of the hippocampus. Neurobiology of Aging 2008, 29:129-147.
48. Zhu M., Gu F., Shi J., Hu J., Hu Y., Zhao Z. Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2. Free Radical Biology and Medicine 2008, 45:1493-1499.
49. Mora F., Segovia G., Del Arco A. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Brain Research Reviews 2007.